Kenya Medical Supplies Agency (Kemsa) was yesterday put on the spot by a parliamentary committee for handpicking a firm to supply reagents and consumables for use under the controversial leased medical equipment, currently under probe in the Senate.
Kemsa CEO Jonah Manjari was at pains to explain to the ad-hoc committee of the Senate inquiring into the Sh63 billion Managed Equipment Services (MES) programme why they single-sourced suppliers of the reagents instead of tendering for the services.